// App-Quantinova.ai

CT215 : Next generation sequencing (NGS) results

Researchers

Presenter

  • Edward Garon

Principal Investigators

  • Martin Reck

  • Kazuto Nishio

  • John Victor Heymach

  • Makoto Nishio

  • Silvia Novello

  • Luis Paz-Ares

  • Sanjay Popat

  • Santiago Ponce Aix

  • Sameera Wijayawardana

  • Rebecca R. Hozak

  • Carla Visseren-Grul

  • Kazuhiko Nakagawa

Medical Centers

  • David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA

  • LungenClinic, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany

  • Department of Medical Oncology, Kinki University, Osaka, Japan

  • The University of Texas MD Anderson Cancer Center Departments of Thoracic/Head & Neck Medical Oncology and Cancer Biology, Houston, TX

  • The Cancer Institute Hospital, Tokyo, Japan

  • University of Turin, Turin, Italy

  • Hospital Universitario Doce de Octubre, Madrid, Spain

  • The Royal Marsden Hospital, London, United Kingdom

  • Medical Oncology Service, Hospital Universitario 12 de Octubre, Madrid, Spain

  • Eli Lilly and Company, Indianapolis, IN

  • Niigata University School of Medicine, Niigata, Japan

Locations

  • United States

  • Germany

  • Japan

  • Italy

  • Spain

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • Anaplastic lymphoma Kinase

  • Epidermal growth factor receptor

  • Tumor protein p53

  • Circulating DNA

Drug/Treatment

  • TP53

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • NCT02411448

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved